Society guideline links: HIV prevention

Introduction — 

This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately:

●(See "Society guideline links: Sexually transmitted infections".)

●(See "Society guideline links: HIV screening and diagnostic testing".)

●(See "Society guideline links: HIV treatment in nonpregnant adults".)

●(See "Society guideline links: HIV treatment in pregnant patients".)

●(See "Society guideline links: Health care for lesbian, gay, and other sexual minority populations".)

International

●World Health Organization (WHO): Consolidated guidelines on HIV, viral hepatitis, and STI prevention, diagnosis, treatment, and care for key populations, update (2022)

●WHO: Guidelines on long-acting injectable cabotegravir for HIV prevention (2022)

●WHO: Preferred product characteristics for monoclonal antibodies for HIV prevention (2022)

●WHO: Consolidated guidelines on HIV prevention, testing, treatment, service delivery, and monitoring – Recommendations for a public health approach, update (2021)

●WHO: Preventing HIV through safe voluntary medical male circumcision for adolescent boys and men in generalized HIV epidemics – Recommendations and key considerations (2020)

Canada

●Canadian Paediatric Society (CPS): Position statement on newborn male circumcision (2015, reaffirmed 2024)

●Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network (CTN): Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis (2017)

United States

●Centers for Disease Control and Prevention (CDC): Guidelines and recommendations for HIV prevention

●New York State Department of Health AIDS Institute (NYSDOH AI): Clinical guidelines program – PEP and PrEP

●American Academy of Pediatrics (AAP): Red Book – Human immunodeficiency virus infection (2024)

●American College of Obstetricians and Gynecologists (ACOG): Committee opinion on preexposure prophylaxis for the prevention of human immunodeficiency virus (2014, reaffirmed 2024)

●ACOG: Practice advisory on preexposure prophylaxis for the prevention of human immunodeficiency virus (2022, reaffirmed 2024)

●HIV Medicine Association (HIVMA) of the Infectious Diseases Society of America (IDSA): Primary care guidance for providers of care for persons with human immunodeficiency virus, update (2024)

●International Antiviral Society-USA Panel (IAS-USA): Recommendations on antiretroviral drugs for treatment and prevention of HIV in adults (2024)

●US Preventive Services Task Force (USPSTF): Final recommendation statement on prevention of acquisition of HIV – Preexposure prophylaxis (2023)

●US Department of Health and Human Services (HHS): Guidelines for the use of antiretroviral agents in adults and adolescents with HIV – Antiretroviral therapy to prevent sexual transmission of HIV (treatment as prevention) (2019)

●Society for Adolescent Health and Medicine (SAHM): A position paper on HIV pre-exposure prophylaxis medication for adolescents and young adults (2018)

Europe

●European AIDS Clinical Society (EACS): Guidelines (2024)

●European Centre for Disease Prevention and Control (ECDC): Operational guidance on HIV pre-exposure prophylaxis in the EU/EEA and the UK – Implementation, standards, and monitoring (2021)

●ECDC: Guidance on HIV and STI prevention among men who have sex with men (2015)

United Kingdom

●British Association for Sexual Health and HIV (BASHH) and British HIVA Association (BHIVA): UK guideline for the use of HIV post-exposure prophylaxis – Post consultation version (2021, amended 2023)

●BHIVA/BASHH: Guidelines on the use of HIV pre-exposure prophylaxis (PrEP) (2018)

●Department of Health and Social Care (DHSC)/UK Chief Medical Officers' Expert Advisory Group on AIDS (EAGA): Guidance on HIV post-exposure prophylaxis (2008, updated 2015)